Financials

News Ideas Technicals

RX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of BIOSYENT INC

Total assets of RX for Q4 23 is 41.53 M CAD, 0.32% more than the previous Q3 23. And total liabilities decreased by 1.11% in Q4 23 to 6.77 M CAD.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: CAD

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—